IFNG and neoplasm: PD-L1 expression is usually low on healthy tissues [84], but is upregulated on various tumor types upon exposure to inflammatory conditions (e.g., IFN-γ) or following activation of key oncogenic pathways involving phosphoinositide 3-kinase (PI3K) or mitogen-activated protein kinase (MAPK).